Federico Rojo

2001–2025 年に発表

120
論文数
19,045
被引用数
69
h 指数
117
i10 指数

被引用数

Federico Rojo の年別被引用数1976 年: 被引用 1 件2001 年: 被引用 3 件2002 年: 被引用 29 件2003 年: 被引用 136 件2004 年: 被引用 160 件2005 年: 被引用 190 件2006 年: 被引用 157 件2007 年: 被引用 147 件2008 年: 被引用 189 件2009 年: 被引用 211 件2010 年: 被引用 221 件2011 年: 被引用 229 件2012 年: 被引用 183 件2013 年: 被引用 156 件2014 年: 被引用 152 件2015 年: 被引用 159 件2016 年: 被引用 126 件2017 年: 被引用 140 件2018 年: 被引用 151 件2019 年: 被引用 592 件2020 年: 被引用 721 件2021 年: 被引用 812 件2022 年: 被引用 587 件2023 年: 被引用 421 件2024 年: 被引用 730 件2025 年: 被引用 380 件2026 年: 被引用 14 件1977〜2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,403 件、この内訳の 24.6%中国: 引用元論文 1,145 件、この内訳の 11.7%イタリア: 引用元論文 593 件、この内訳の 6.1%スペイン: 引用元論文 527 件、この内訳の 5.4%イギリス: 引用元論文 496 件、この内訳の 5.1%ドイツ: 引用元論文 445 件、この内訳の 4.6%フランス: 引用元論文 335 件、この内訳の 3.4%日本: 引用元論文 310 件、この内訳の 3.2%カナダ: 引用元論文 283 件、この内訳の 2.9%オーストラリア: 引用元論文 269 件、この内訳の 2.7%スイス: 引用元論文 227 件、この内訳の 2.3%韓国: 引用元論文 203 件、この内訳の 2.1%
0%24.6%その他 25.9%

分野

  • Medicine55.4%
  • Biochemistry, Genetics and Molecular Biology36.2%
  • Immunology and Microbiology3.7%
  • Computer Science1.9%
  • Neuroscience0.6%
  • Engineering0.5%
  • その他1.7%

トピック

  • HER2/EGFR in Cancer Research6.2%
  • Cancer Cells and Metastasis4.4%
  • Cancer Immunotherapy and Biomarkers4.3%
  • PI3K/AKT/mTOR signaling in cancer3.9%
  • Lung Cancer Treatments and Mutations2.9%
  • Monoclonal and Polyclonal Antibodies Research2.8%
  • その他75.5%

共著者

全論文

検索で開く
  1. ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fabrice André, G. Curigliano - Annals of Oncology 2023 被引用: 299

  2. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 被引用: 799

  3. Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2018 被引用: 442

  4. Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane B. Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André L. Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 被引用: 720

  5. Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Seminars in Cancer Biology 2017 被引用: 432

  6. Expression of p95HER2, a Truncated Form of the HER2 Receptor, and Response to Anti-HER2 Therapies in Breast Cancer

    著者: , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2007 被引用: 881

  7. Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeroen van der Laak, Francesco Ciompi, Anne‐Vibeke Lænkholm, Enrique Bellolio, Tina Gruosso, Stephen B. Fox, Juan Carlos Araya, Giuseppe Floris, Jan Hudeček, Leonie Voorwerk, Andrew H. Beck, J. Kaplan Kerner, Denis Larsimont, Sabine Declercq, Gert Van den Eynden, Lajos Pusztai, Anna Ehinger, Wentao Yang, Khalid AbdulJabbar, Yinyin Yuan, Rajendra Singh, Crispin T. Hiley, Maise Al Bakir, Alexander J. Lazar, Stephen P. Naber, Stephan Wienert, Miluska Castillo, Giuseppe Curigliano, Maria Vittoria Dieci, Fabrice André, Charles Swanton, Jorge S. Reis‐Filho, Joseph A. Sparano, Eva Balslev, I‐Chun Chen, Elisabeth Ida Specht Stovgaard, Katherine L. Pogue–Geile, Kim Blenman, Frédérique Penault–Llorca, Stuart J. Schnitt, Sunil R. Lakhani, Anne Vincent‐Salomon, Federico Rojo, Jeremy Braybrooke, Matthew G. Hanna, María Teresa Soler-Monsó, Daniel Bethmann, Carlos Castaneda, Karen Willard‐Gallo, Ashish Sharma, Huang‐Chun Lien, Susan Fineberg, Jeppe Thagaard, Laura Comerma, Paula I. González-Ericsson, Edi Brogi, Sherene Loi, Joel Saltz, Frederick Klaushen, Lee Cooper, Mohamed Amgad, David Moore, Roberto Salgado, the International Immuno-Oncology Biomarker Working Group, Aini Hyytiäinen, Akira I. Hida, Alastair Thompson, Alexis Lefevre, Allen M. Gown, Amy Lo ほか 156 名 - npj Breast Cancer 2020 被引用: 206

  8. Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giancarlo Pruneri, Sandra Demaria, Sylvia Adams, Stuart J. Schnitt, Sunil R. Lakhani, Federico Rojo, Laura Comerma, Sunil Badve, Mehrnoush Khojasteh, W. Fraser Symmans, Christos Sotiriou, Paula I. González-Ericsson, Katherine L. Pogue–Geile, Rim S. Kim, David L. Rimm, Giuseppe Viale, Stephen M. Hewitt, John M. S. Bartlett, Frédérique Penault–Llorca, Shom Goel, Huang‐Chun Lien, Sibylle Loibl, Zuzana Kos, Sherene Loi, Matthew G. Hanna, Stefan Michiels, Marleen Kok, Torsten O. Nielsen, Alexander J. Lazar, Zsuzsanna Bagó-Horváth, Loes Kooreman, Jeroen van der Laak, Joel Saltz, Brandon D. Gallas, Uday Kurkure, Michael Barnes, Roberto Salgado, Lee Cooper, International Immuno-Oncology Biomarker Working Group, Aini Hyytiäinen, Akira I. Hida, Alastair M. Thompson, Alexis Lefevre, Allen M. Gown, Amy Lo, Anna Sapino, André L. Moreira, Andrea L. Richardson, Andrea Vingiani, Andrew M. Bellizzi, Andrew Tutt, Ángel Guerrero‐Zotano, Anita Grigoriadis, Anna Ehinger, Ana C. Garrido-Castro, Anne Vincent-Salomon, Anne‐Vibeke Lænkholm, Ashley Cimino‐Mathews, Ashok Srinivasan, Balázs Ács, Baljit Singh, Benjamin C. Calhoun, Benjamin Haibe-Kans, Benjamin Solomon, Bibhusal Thapa, Brad H. Nelson, Carlos Castaneda, Carmen Ballesteroes-Merino, Carmen Criscitiello, Carolien Boeckx ほか 158 名 - npj Breast Cancer 2020 被引用: 166

  9. A SNAIL1–SMAD3/4 transcriptional repressor complex promotes TGF-β mediated epithelial–mesenchymal transition

    著者: , , , , , , , , , , , , , , - Nature Cell Biology 2009 被引用: 636

  10. High Interobserver Variability Among Pathologists Using Combined Positive Score to Evaluate PD-L1 Expression in Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma

    著者: , , , , , , , , , , , , , , , , , - Modern Pathology 2023 被引用: 61

  11. Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer

    著者: , , , , , , , , , , , , , , - Journal of Clinical Investigation 2008 被引用: 1,365

  12. Distinct GSDMB protein isoforms and protease cleavage processes differentially control pyroptotic cell death and mitochondrial damage in cancer cells

    著者: , , , , , , , , , , , , , , , , , , , , - Cell Death and Differentiation 2023 被引用: 77

  13. International real-world study of DLL3 expression in patients with small cell lung cancer

    著者: , , , , , , , , , , , , , - Lung Cancer 2020 被引用: 74

  14. Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Research 2017 被引用: 251

  15. FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2020 被引用: 110

  16. NK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival

    著者: , , , , , , , , , , , , , , - Clinical Cancer Research 2019 被引用: 131

  17. Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2017 被引用: 96

  18. Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation

    著者: , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2019 被引用: 109

  19. PKB/Akt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization

    著者: , , , , , , - Nature Medicine 2002 被引用: 786

  20. High TGFβ-Smad Activity Confers Poor Prognosis in Glioma Patients and Promotes Cell Proliferation Depending on the Methylation of the PDGF-B Gene

    著者: , , , , , , , , , , - Cancer Cell 2007 被引用: 477

  21. Vitamin D receptor expression and associated gene signature in tumour stromal fibroblasts predict clinical outcome in colorectal cancer

    著者: , , , , , , , , , - Gut 2016 被引用: 188

  22. Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Science Advances 2022 被引用: 56

  23. Palbociclib Rechallenge for Hormone Receptor–Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2022 被引用: 37

  24. NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Experimental & Clinical Cancer Research 2024 被引用: 32